DalsnaFinance › IPOs › Aktis Oncology, Inc.
Aktis Oncology, Inc. completed its initial public offering on NASDAQ on January 9, 2026, pricing at $18.00 a share.
| Ticker | AKTS |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | January 9, 2026 |
| Offering price | $18.00 |
| Shares offered | 17,650,000 |
| Total raised | $318M |
Aktis Oncology, Inc. — quote, profile and latest news →
IPO data is compiled from SEC filings. This page is general information, not investment advice.